EPI Health, LLC recalls minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only,
Recalled October 2, 2019 · FDA recall D-0120-2020 · EPI Health
Hazard
Failed Dissolution Specifications: · FDA Class III
Units
1,626 5-count bottles
Sold at
Firm recalling only from EPI Field Representatives.
Description
Failed Dissolution Specifications:
Product
minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.
Manufacturer(s)
EPI Health, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →